Eptifibatide acetate
Eptifibatide, also co-promoted by Schering-Plough/Essex, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri) . It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
Product Specifications
CAS Number
1248559-53-6
Field of Research
Pharmacology & Drug Discovery
Purity
>98%
Smiles
NC (NCCCC[C@@H]1NC (CCSSC[C@@H] (C (N) =O) NC ([C@@H]2CCCN2C ([C@@H] (NC ([C@@H] (NC (CNC1=O) =O) CC (O) =O) =O) Cc (c[nH]3) c4c3cccc4) =O) =O) =O) =N
Molecular Formula
C37H53N11O11S2
Molecular Weight
892.01
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
